RIOK2 phosphorylation by RSK promotes synthesis of the human small ribosomal subunit.


Journal

PLoS genetics
ISSN: 1553-7404
Titre abrégé: PLoS Genet
Pays: United States
ID NLM: 101239074

Informations de publication

Date de publication:
06 2021
Historique:
received: 29 04 2021
accepted: 05 05 2021
revised: 24 06 2021
pubmed: 15 6 2021
medline: 28 10 2021
entrez: 14 6 2021
Statut: epublish

Résumé

Ribosome biogenesis lies at the nexus of various signaling pathways coordinating protein synthesis with cell growth and proliferation. This process is regulated by well-described transcriptional mechanisms, but a growing body of evidence indicates that other levels of regulation exist. Here we show that the Ras/mitogen-activated protein kinase (MAPK) pathway stimulates post-transcriptional stages of human ribosome synthesis. We identify RIOK2, a pre-40S particle assembly factor, as a new target of the MAPK-activated kinase RSK. RIOK2 phosphorylation by RSK stimulates cytoplasmic maturation of late pre-40S particles, which is required for optimal protein synthesis and cell proliferation. RIOK2 phosphorylation facilitates its release from pre-40S particles and its nuclear re-import, prior to completion of small ribosomal subunits. Our results bring a detailed mechanistic link between the Ras/MAPK pathway and the maturation of human pre-40S particles, which opens a hitherto poorly explored area of ribosome biogenesis.

Identifiants

pubmed: 34125833
doi: 10.1371/journal.pgen.1009583
pii: PGENETICS-D-21-00585
pmc: PMC8224940
doi:

Substances chimiques

Protein Serine-Threonine Kinases EC 2.7.11.1
RIOK2 protein, human EC 2.7.11.1
Mitogen-Activated Protein Kinases EC 2.7.11.24

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1009583

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

RNA. 2008 Oct;14(10):2061-73
pubmed: 18755838
Mol Biol Cell. 2012 Jan;23(1):22-35
pubmed: 22072790
Cell. 2012 Oct 26;151(3):671-83
pubmed: 23101633
Science. 2017 Nov 3;358(6363):
pubmed: 29097519
Mol Biol Cell. 2016 Jan 15;27(2):397-409
pubmed: 26582391
RNA Biol. 2012 Feb;9(2):162-74
pubmed: 22418843
Semin Cancer Biol. 2018 Feb;48:53-61
pubmed: 28476656
EMBO J. 2019 Jul 1;38(13):e100278
pubmed: 31268599
EMBO Rep. 2018 Aug;19(8):
pubmed: 29895711
PLoS Genet. 2018 Feb 5;14(2):e1007202
pubmed: 29401457
Mol Cell. 2013 Aug 22;51(4):539-51
pubmed: 23973377
PLoS Biol. 2010 Oct 26;8(10):e1000522
pubmed: 21048991
Trends Biochem Sci. 2017 Aug;42(8):640-654
pubmed: 28579196
Int J Mol Sci. 2019 Jun 03;20(11):
pubmed: 31163577
RNA. 2009 Dec;15(12):2083-104
pubmed: 19850913
Biochim Biophys Acta. 2010 Jun;1803(6):673-83
pubmed: 19879902
J Biol Chem. 1996 Nov 22;271(47):29773-9
pubmed: 8939914
Nat Commun. 2019 Jun 21;10(1):2754
pubmed: 31227701
Nat Struct Mol Biol. 2012 Dec;19(12):1316-23
pubmed: 23104056
Mol Cell. 2001 Nov;8(5):1063-73
pubmed: 11741541
Mol Cell Biol. 2003 Mar;23(6):2083-95
pubmed: 12612080
J Cell Biol. 2009 Jun 29;185(7):1167-80
pubmed: 19564402
PLoS Genet. 2013;9(2):e1003253
pubmed: 23459592
Nat Commun. 2016 Feb 02;7:10336
pubmed: 26831757
Oncogene. 2013 Jun 13;32(24):2917-2926
pubmed: 22797077
Nucleic Acids Res. 2014;42(17):11180-91
pubmed: 25190460
EMBO J. 2003 May 15;22(10):2422-32
pubmed: 12743036
Nat Rev Mol Cell Biol. 2020 Apr;21(4):183-203
pubmed: 31937935
Nucleic Acids Res. 2008 Sep;36(15):5093-101
pubmed: 18676449
Nat Methods. 2017 Jun;14(6):615-620
pubmed: 28417998
Nat Rev Drug Discov. 2019 Jul;18(8):574
pubmed: 31367048
Gene. 2015 Feb 1;556(1):27-34
pubmed: 25447905
J Cell Sci. 2014 Mar 15;127(Pt 6):1242-53
pubmed: 24424021
J Cell Biol. 2010 Sep 6;190(5):853-66
pubmed: 20819938
Nucleic Acids Res. 2017 Jun 20;45(11):6822-6836
pubmed: 28402503
J Cell Biol. 2015 Mar 16;208(6):745-59
pubmed: 25778921
Biochim Biophys Acta. 2005 Dec 30;1754(1-2):14-24
pubmed: 16182620
Biochem J. 2012 Jan 15;441(2):553-69
pubmed: 22187936
Cell Signal. 1992 Nov;4(6):665-74
pubmed: 1489659
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4441-5
pubmed: 8183928
Mol Cell Biol. 2014 Dec;34(24):4474-84
pubmed: 25288641
Wiley Interdiscip Rev RNA. 2019 Jan;10(1):e1516
pubmed: 30406965
Cell Rep. 2015 Dec 29;13(12):2879-91
pubmed: 26711351
Nucleic Acids Res. 2012 Sep 1;40(17):8646-61
pubmed: 22735702
RNA Biol. 2019 Nov;16(11):1633-1642
pubmed: 31390939
Genes Dev. 2003 Jul 15;17(14):1691-702
pubmed: 12865296
Nucleic Acids Res. 2018 Feb 16;46(3):1441-1456
pubmed: 29237037
Cell Rep. 2018 Feb 13;22(7):1923-1934
pubmed: 29444442
J Biol Chem. 2000 Apr 14;275(15):11249-56
pubmed: 10753934
Oncogene. 2014 Jan 23;33(4):474-83
pubmed: 23318442
RNA. 2011 Jan;17(1):189-200
pubmed: 21097556
EMBO J. 2005 Aug 17;24(16):2862-72
pubmed: 16037817
Mol Cell. 2003 Feb;11(2):405-13
pubmed: 12620228
Nucleic Acids Res. 2012 Mar;40(6):2527-39
pubmed: 22121221
J Neurochem. 2011 Nov;119(3):447-59
pubmed: 21838783
Immunity. 2003 Oct;19(4):535-48
pubmed: 14563318
Biochem J. 2012 Oct 1;447(1):159-66
pubmed: 22827337
Elife. 2015 Apr 21;4:
pubmed: 25895666
Nat Commun. 2020 Jan 9;11(1):156
pubmed: 31919354
J Biol Chem. 2007 May 11;282(19):14056-64
pubmed: 17360704
Microbiol Mol Biol Rev. 2011 Mar;75(1):50-83
pubmed: 21372320
J Biol Chem. 2002 Mar 29;277(13):11591-6
pubmed: 11799119
J Mol Cell Cardiol. 2013 Jun;59:139-47
pubmed: 23510923
Science. 2000 May 26;288(5470):1385-9
pubmed: 10827942
Biomolecules. 2018 Oct 24;8(4):
pubmed: 30356013
Nature. 2018 Jun;558(7709):249-253
pubmed: 29875412
Mol Cell Biol. 2010 Jun;30(12):2947-56
pubmed: 20404093
J Cell Mol Med. 2020 Apr;24(8):4494-4509
pubmed: 32125767
J Biol Chem. 2011 Oct 21;286(42):36352-60
pubmed: 21880710
EMBO J. 2006 Aug 23;25(16):3832-42
pubmed: 16888624
RNA Biol. 2019 Feb;16(2):196-210
pubmed: 30638116
Mol Cell Biol. 2001 Jan;21(1):81-7
pubmed: 11113183
Nature. 2006 Jun 1;441(7093):651-5
pubmed: 16738661
Mol Cell. 2006 Mar 3;21(5):629-39
pubmed: 16507361
Trends Biochem Sci. 1999 Nov;24(11):437-40
pubmed: 10542411
Genetics. 2013 Nov;195(3):643-81
pubmed: 24190922
Nat Methods. 2009 Apr;6(4):275-7
pubmed: 19305406
Biochemistry. 2006 Mar 21;45(11):3626-34
pubmed: 16533045
Wiley Interdiscip Rev RNA. 2015 Mar-Apr;6(2):225-42
pubmed: 25346433
J Biol Chem. 2003 Jun 20;278(25):22537-45
pubmed: 12690111
Mol Cell Biol. 1982 Jun;2(6):685-93
pubmed: 14582163
Cell Cycle. 2007 Oct 1;6(19):2323-6
pubmed: 17938580

Auteurs

Emilie L Cerezo (EL)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Thibault Houles (T)

Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Québec, Canada.

Oriane Lié (O)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Marie-Kerguelen Sarthou (MK)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Charlotte Audoynaud (C)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Geneviève Lavoie (G)

Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Québec, Canada.

Maral Halladjian (M)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Sylvain Cantaloube (S)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Carine Froment (C)

Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, UPS, CNRS, Toulouse, France.

Odile Burlet-Schiltz (O)

Institut de Pharmacologie et Biologie Structurale (IPBS), Université de Toulouse, UPS, CNRS, Toulouse, France.

Yves Henry (Y)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Philippe P Roux (PP)

Institute for Research in Immunology and Cancer, Université de Montréal, Montreal, Québec, Canada.
Department of Pathology and Cell Biology, Faculty of Medicine, Université de Montréal, Montreal, Québec, Canada.

Anthony K Henras (AK)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Yves Romeo (Y)

Molecular, Cellular and Developmental biology department (MCD), Centre de Biologie Intégrative (CBI), Université de Toulouse, CNRS, UPS, Toulouse, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH